| Line 73: |
Line 73: |
| | best results seem to occur with early treatment, | | best results seem to occur with early treatment, |
| | although a 9-12 month trial is necessary to assess | | although a 9-12 month trial is necessary to assess |
| − | the response in each case. Animals on ASIT | + | the response in each case. |
| − | require careful supervision to control microbial
| + | |
| − | infections and other flare factors, to administer
| |
| − | anti-inflammatory treatment as required and to
| |
| − | adjust the dose and/or frequency according
| |
| − | to the clinical response (Figure 1).
| |
| | The exact protocol varies widely but usually | | The exact protocol varies widely but usually |
| | involves repeated injections a few days to 1-2 | | involves repeated injections a few days to 1-2 |
| | weeks apart. Once the full dose is reached, the | | weeks apart. Once the full dose is reached, the |
| | interval between injections can be extended. | | interval between injections can be extended. |
| − | A rush protocol, where the initial loading course
| + | |
| − | is given within a single day, was recently shown
| |
| − | to be as effective as conventional ASIT in a small
| |
| − | number of dogs (7). Recent reports also described
| |
| − | starting with a full dose (monodose therapy).
| |
| − | No adverse effects were seen in either case
| |
| − | although the dogs were pre-medicated with
| |
| − | an anti-histamine.
| |
| − | Alum precipitated vaccines have a depot effect
| |
| − | and require less frequent administration. Alum
| |
| − | adjuvants potentiate IgE responses in experimental
| |
| − | animals but no differences in efficacy between
| |
| − | alum-precipitated and aqueous vaccines have been
| |
| − | demonstrated in dogs. There are anecdotal reports
| |
| − | of improved efficacy with low dose ASIT, but a
| |
| − | controlled study, however, found no difference in
| |
| − | efficacy between low dose and conventional
| |
| − | alum-precipitated ASIT (8).
| |
| | If ASIT proves successful, the interval between | | If ASIT proves successful, the interval between |
| | injections can be extended. Increased pruritus | | injections can be extended. Increased pruritus |
| Line 109: |
Line 88: |
| | but most require maintenance injections every | | but most require maintenance injections every |
| | 1-2 months. | | 1-2 months. |
| − | Re-testing may reveal new sensitivities in dogs
| + | |
| − | with initially negative tests, dogs <12 months
| |
| − | old at the time of the original test, if there has
| |
| − | been a poor response to ASIT or where a good
| |
| − | response is not maintained. Re-formulating ASIT
| |
| − | can be beneficial in these dogs.
| |
| | Adverse effects are uncommon. Injection site | | Adverse effects are uncommon. Injection site |
| | reactions and anaphylactic shock are very rare, | | reactions and anaphylactic shock are very rare, |
| | although many dermatologists advise giving the | | although many dermatologists advise giving the |
| − | first 5-6 doses in a veterinary clinic. Increased | + | first 5-6 doses in a veterinary clinic. |
| − | pruritus after an injection indicates that the dose is
| |
| − | too high although mild reactions can sometimes be
| |
| − | managed with antihistamines.
| |
| | | | |
| | ===Anti-inflammatory therapy=== | | ===Anti-inflammatory therapy=== |